Two Cases of Methimazole-Induced Agranulocytosis With Their Risk Factors

BACKGROUND: Antithyroid drugs, such as methimazole (MMI), are standard therapies for the medical management of thyrotoxicosis. Agranulocytosis is a rare but lethal adverse effect of antithyroid medications. We have reported 2 cases of MMI-induced agranulocytosis with similar risk factors that likely...

Descripción completa

Detalles Bibliográficos
Autores principales: Khine, Aye, Dhillon, Kiranjit, Jo, Linda, Wormser, Vanessa, Naing, Soe, Mishra, Shreela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Clinical Endocrinology 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984507/
https://www.ncbi.nlm.nih.gov/pubmed/35415227
http://dx.doi.org/10.1016/j.aace.2021.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984507/
https://www.ncbi.nlm.nih.gov/pubmed/35415227
http://dx.doi.org/10.1016/j.aace.2021.10.005

Ejemplares similares